Anna Liveris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna Liveris has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Edward Chao
NYC Health+Hospitals/Jacobi, Surgery, Bronx, New York
4 shared publications - Carlos Vargas
Department of Surgery, Jacobi Medical Center Bronx, NY, United States
2 shared publications - Dalia Alqunaibit
Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY, 10461, USA; Jacobi Medical Center, 1400 Pelham Parkway South, Bronx, NY, 10461, USA
2 shared publications - Michael P. Jones
Department of Emergency Medicine Albert Einstein College of Medicine, Montefiore Bronx New York USA
2 shared publications - Samuel Weinstein
Cardiothoracic and Vascular Surgery, Montefiore Medical Center, New York, NY
2 shared publications - Sheldon H. Teperman
Jacobi Medical Center, 1400 Pelham Parkway South, Bronx, NY, 10461, USA
2 shared publications
Latest Publications
- 28 March 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 244, 116320
Increased incidence of complicated appendicitis in patients with neurodevelopmental disabilities
- 28 March 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 244, 116320
Increased incidence of complicated appendicitis in patients with neurodevelopmental disabilities
- Open Access
- 20 September 2022
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 9 (3) , 198-206
“Diffusion of innovations”: a feasibility study on the pericapsular nerve group block in the emergency department for hip fractures
Objective Hip fractures are associated with significant morbidity and mortality. Ultrasound-guided peripheral nerve blocks are a safe method to manage pain and decrease opioid usage. The pericapsular nerve group (PENG) block is a novel, potentially superior block because of its motor-sparing effects. Through training, simulation, and supervision, we aim to determine whether it is feasible to perform the PENG block in the emergency department.Methods Phase 1 consisted of emergency physicians attending a workshop to demonstrate ultrasound proficiency, anatomical understanding, and procedural competency using a low-fidelity model. Phase 2 consisted of a prospective, observational, feasibility study of 10 patients with hip fractures. Pain scores, side effects, and opioid usage data were collected.Results The median pain score at time 0 (time of block) was 9 (interquartile range [IQR], 6.5–9). The median pain score at 30 minutes was 4 (IQR, 2.0–6.8) and 3.5 (IQR, 1.0–4.8) at 4 hours. All 10 patients required narcotics prior to the initiation of the PENG block with a median dosage of 6.25 morphine milligram equivalents (MME; IQR, 4.25–7.38 MME). After the PENG block, only 30% of the patients required further narcotics with a median dosage of 0 MME (IQR, 0–0.6 MME) until operative fixation.Conclusion In this feasibility study, PENG blocks were safely administered by trained emergency physicians under supervision. We demonstrated data suggesting a trend of pain relief and decreased opiate requirements, and further investigation is necessary to measure efficacy.
- 20 September 2022
- Published by The Korean Society of Emergency Medicine in Clinical and Experimental Emergency Medicine
- Vol. 9 (3) , 198-206
Open Access“Diffusion of innovations”: a feasibility study on the pericapsular nerve group block in the emergency department for hip fractures
Objective Hip fractures are associated with significant morbidity and mortality. Ultrasound-guided peripheral nerve blocks are a safe method to manage pain and decrease opioid usage. The pericapsular nerve group (PENG) block is a novel, potentially superior block because of its motor-sparing effects. Through training, simulation, and supervision, we aim to determine whether it is feasible to perform the PENG block in the emergency department.Methods Phase 1 consisted of emergency physicians attending a workshop to demonstrate ultrasound proficiency, anatomical understanding, and procedural competency using a low-fidelity model. Phase 2 consisted of a prospective, observational, feasibility study of 10 patients with hip fractures. Pain scores, side effects, and opioid usage data were collected.Results The median pain score at time 0 (time of block) was 9 (interquartile range [IQR], 6.5–9). The median pain score at 30 minutes was 4 (IQR, 2.0–6.8) and 3.5 (IQR, 1.0–4.8) at 4 hours. All 10 patients required narcotics prior to the initiation of the PENG block with a median dosage of 6.25 morphine milligram equivalents (MME; IQR, 4.25–7.38 MME). After the PENG block, only 30% of the patients required further narcotics with a median dosage of 0 MME (IQR, 0–0.6 MME) until operative fixation.Conclusion In this feasibility study, PENG blocks were safely administered by trained emergency physicians under supervision. We demonstrated data suggesting a trend of pain relief and decreased opiate requirements, and further investigation is necessary to measure efficacy.
- Open Access
- 22 October 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , S279-S280
Late Tracheostomy When New York City Was the COVID-19 Epicenter: Was it Worth the Wait?
During New York City's (NYC) time as the world's COVID-19 epicenter, there was unclear guidance on when to perform tracheostomy for COVID-19+ patients. We hypothesized that early tracheostomy (≤14 days) would demonstrate improvement in clinical outcomes over late tracheostomy.
- 22 October 2021
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 233 (5) , S279-S280
Open AccessLate Tracheostomy When New York City Was the COVID-19 Epicenter: Was it Worth the Wait?
During New York City's (NYC) time as the world's COVID-19 epicenter, there was unclear guidance on when to perform tracheostomy for COVID-19+ patients. We hypothesized that early tracheostomy (≤14 days) would demonstrate improvement in clinical outcomes over late tracheostomy.
- 18 June 2019
- Published by Springer Nature in Current Geriatrics Reports
- Vol. 8 (3) , 160-166
Delirium in the Elderly Surgical Patient
- 18 June 2019
- Published by Springer Nature in Current Geriatrics Reports
- Vol. 8 (3) , 160-166
Delirium in the Elderly Surgical Patient
- Open Access
- 7 July 2018
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 37, 27-29
Cecal epiploic appendagitis mimicking appendicitis
- 7 July 2018
- Published by Elsevier in Journal of Pediatric Surgery Case Reports
- Vol. 37, 27-29
Open AccessCecal epiploic appendagitis mimicking appendicitis
- 1 December 2015
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 43, 285
1133
- 1 February 2014
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 15 (2) , e72-e79
Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation*
Objective: To assess the utility of activated clotting time, activated partial thromboplastin time, and anti-Factor Xa assay for the monitoring and dosing of heparin in pediatric patients requiring support with extracorporeal membrane oxygenation. Design: Retrospective chart review. Setting: PICU in a single, tertiary care, academic children’s hospital. Patients: Seventeen patients (age 1 d to 13.9 yr, median 0.83 yr) managed on pulmonary and cardiac extracorporeal membrane oxygenation between March 2010 and August 2012 by a single surgeon. Interventions: None. Measurements and Main Results: Twice daily measurements of anti-Factor Xa assay, activated clotting time, and activated partial thromboplastin time were determined from the same blood specimen. Data were analyzed using SAS system v9.2. Fourteen patients (82.4%) were successfully weaned from extracorporeal membrane oxygenation and 12 (70.6%) were discharged from the hospital. Pearson correlations were used to compare heparin dose and activated clotting time, activated partial thromboplastin time, and anti-Factor Xa assay. Analysis showed negative Pearson correlations in 11 of 17 patients between the activated clotting time and heparin, as compared with seven of 17 for activated partial thromboplastin time and only one for heparin and anti-Factor Xa assay. Only four patients had moderate to strong positive correlations between activated clotting time and heparin as compared with a moderate to strong positive correlation in 10 patients for anti-Factor Xa assay and heparin. Conclusions: The anti-Factor Xa assay correlated better with heparin dosing than activated clotting time or activated partial thromboplastin time. Activated clotting time has a poor correlation to heparin doses commonly associated with extracorporeal membrane oxygenation. In pediatric extracorporeal membrane oxygenation, anti-Factor Xa assay may be a more valuable monitor of heparin administration.
- 1 February 2014
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 15 (2) , e72-e79
Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation*
Objective: To assess the utility of activated clotting time, activated partial thromboplastin time, and anti-Factor Xa assay for the monitoring and dosing of heparin in pediatric patients requiring support with extracorporeal membrane oxygenation. Design: Retrospective chart review. Setting: PICU in a single, tertiary care, academic children’s hospital. Patients: Seventeen patients (age 1 d to 13.9 yr, median 0.83 yr) managed on pulmonary and cardiac extracorporeal membrane oxygenation between March 2010 and August 2012 by a single surgeon. Interventions: None. Measurements and Main Results: Twice daily measurements of anti-Factor Xa assay, activated clotting time, and activated partial thromboplastin time were determined from the same blood specimen. Data were analyzed using SAS system v9.2. Fourteen patients (82.4%) were successfully weaned from extracorporeal membrane oxygenation and 12 (70.6%) were discharged from the hospital. Pearson correlations were used to compare heparin dose and activated clotting time, activated partial thromboplastin time, and anti-Factor Xa assay. Analysis showed negative Pearson correlations in 11 of 17 patients between the activated clotting time and heparin, as compared with seven of 17 for activated partial thromboplastin time and only one for heparin and anti-Factor Xa assay. Only four patients had moderate to strong positive correlations between activated clotting time and heparin as compared with a moderate to strong positive correlation in 10 patients for anti-Factor Xa assay and heparin. Conclusions: The anti-Factor Xa assay correlated better with heparin dosing than activated clotting time or activated partial thromboplastin time. Activated clotting time has a poor correlation to heparin doses commonly associated with extracorporeal membrane oxygenation. In pediatric extracorporeal membrane oxygenation, anti-Factor Xa assay may be a more valuable monitor of heparin administration.
- 1 March 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (3) , 876-878
Bilateral pulmonary arterial banding for complex transposition of the great arteries
- 1 March 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (3) , 876-878
Bilateral pulmonary arterial banding for complex transposition of the great arteries